VACT-CP Group for Chronic Pain

Phase-Based Progress Estimates
Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA, Bedford, MAChronic PainVeteran Acceptance and Commitment Therapy for Chronic Pain - Behavioral
All Sexes
What conditions do you have?

Study Summary

This trial will develop a virtual ACT intervention for chronic pain (VACT-CP) for Veterans, which will utilize a personalized, social interface to address pain-related distress and functional difficulties of chronic pain.

Treatment Effectiveness

Study Objectives

2 Primary · 6 Secondary · Reporting Duration: Post-Intervention, at 8 weeks

Post-Intervention, at 8 weeks
System Usability Scale (SUS)
Week 8
Client Satisfaction Questionnaire-8 (CSQ-8)
Multidimensional Experiential Avoidance Questionnaire (MEAQ)
Pain Numeric Rating Scale
Pain Outcomes Questionnaire - VA (POQ - VA)
The Chronic Pain Acceptance Questionnaire (CPAQ)
Usability Survey

Trial Safety

Trial Design

2 Treatment Groups

Waitlist Control Group
1 of 2
1 of 2

Active Control

Experimental Treatment

40 Total Participants · 2 Treatment Groups

Primary Treatment: VACT-CP Group · No Placebo Group · N/A

Experimental Group · 1 Intervention: Veteran Acceptance and Commitment Therapy for Chronic Pain · Intervention Types: Behavioral
Waitlist Control GroupNoIntervention Group · 1 Intervention: Waitlist Control Group · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: post-intervention, at 8 weeks

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,496 Previous Clinical Trials
2,724,358 Total Patients Enrolled
33 Trials studying Chronic Pain
4,058 Patients Enrolled for Chronic Pain
Erin D. Reilly, PhDPrincipal InvestigatorVA Bedford HealthCare System, Bedford, MA
1 Previous Clinical Trials
15 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

What is the objective of this research endeavor?

"The main measure used to gauge success of this trial is a Usability Survey at the 8-week Post-Intervention. Additionally, The Chronic Pain Values Inventory (CPVI), Pain Numeric Rating Scale and The Chronic Pain Acceptance Questionnaire (CPAQ) will also be employed as secondary outcome metrics. CPVI consists of 6 importance ratings from 0 to 5 and corresponding 6 success ratings which are averaged together for a score ranging from 1 - 6; whereas, CPAQ has an Activity Engagement subscale with 11 items scaling up to 77 points, in addition to 9 items on the Pain Willingness scale that can reach" - Anonymous Online Contributor

Unverified Answer

How many participants can be involved in this research endeavor?

"Affirmative. According to, this experimental trial is currently enrolling participants since its inception on March 17th 2022 and last revised on May 2nd 2022. The study requires 40 volunteers that can be recruited from two different sites." - Anonymous Online Contributor

Unverified Answer

Are there any vacancies still available for potential participants of this research?

"Affirmative. data suggests that this trial is presently recruiting participants, which began on March 17th 2022 and was last modified on May 2nd 2022. The study requires 40 patients to be enrolled at two separate sites." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.